ArticleJournal of global oncology2017
Cancer Trends in Mexico: Essential Data for the Creation and Follow-Up of Public Policies.
Article in Journal of global oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Residual Primary Breast Cancer After Chemotherapy: Assessment of Recurrence and Survival.Cureus · 2026Article
- Assessing disparities in cancer resources distribution in Mexico.BMC health services research · 2025Article
- Trends in the burden of HPV-associated cancers in Mexico: An analysis from 2011 to 2019.PloS one · 2025Article
- Cancer epidemiology in pathology of a hospital in eastern MexicoRevista medica del Instituto Mexicano del Seguro Social · 2024Article
- Primary Peritoneal Serous Cancer: A Case Report of a Tumor in the Rectovaginal Septum.Case reports in oncological medicine · 2024Article
- Article
- [Availability of mammographs in Mexico: Is it possible to expand coverage].Revista medica del Instituto Mexicano del Seguro Social · 2023Observational
- Regional and national burden of prostate cancer: incidence, mortality, years of life lost, and disability-adjusted life years, in Mexico and Latin America from 1990 to 2019.International urology and nephrology · 2023Article
- Relationship between Health Inequalities and Breast Cancer Survival in Mexican Women.International journal of environmental research and public health · 2023Article
- Article
- Differences in the Glenohumeral Joint before and after Unilateral Breast Cancer Surgery: Motion Capture Analysis.Healthcare (Basel, Switzerland) · 2022Article
- Prognostic factors in cancer patients infected with SARS-CoV-2: a Latin American country results.Therapeutic advances in chronic disease · 2021Article
- Cervical Cancer in Young Women: Do They Have a Worse Prognosis? A Retrospective Cohort Analysis in a Population of Mexico.The oncologist · 2020Article
- Availability, prices, and affordability of selected essential cancer medicines in a middle-income country - the case of Mexico.BMC health services research · 2020Article
- Patient Navigation to Enhance Access to Care for Underserved Patients with a Suspicion or Diagnosis of Cancer.The oncologist · 2019Article
- The influence of medical providers on HPV vaccination among children of Mexican mothers: a comparison between Mexico and the Midwest region of the United States.BMC public health · 2019Article
- Article
- Development of a Nanostructured Platform for Identifying HER2-Heterogeneity of Breast Cancer Cells by Surface-Enhanced Raman Scattering.Nanomaterials (Basel, Switzerland) · 2018Article
- Disability-Adjusted Life Years for Cancer in 2010⁻2014: A Regional Approach in Mexico.International journal of environmental research and public health · 2018Article
- Cancer Prevention Behaviors in Workers of a Referral Cancer Center in Mexico City: A Pilot Study on Early Detection Awareness for Cancer.Cancer control : journal of the Moffitt Cancer CenterArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose Cancer in a country like Mexico is a challenge for the current health system and for public health. However, the statistics about cancer in Mexico are scarce, so epidemiologic surveillance needs to be improved. The objectives of this article were to describe the extent of cancer and to estimate the national burden of cancer through 2020. Materials and Methods To meet this objective, an analysis of secondary official sources was performed. The cancer cases through 2020 were estimated on the basis of trends in mortality and the projection of incident cases reported by GLOBOCAN. Results In 2013, cancer was the cause of 12.84% of all deaths in Mexico. It is projected that the prevalence of cancer will be 904,581 by 2017 and will reach 1,262,861 by early in the next decade (ie, 2020). Conclusion Available data for cancer are incomplete. The development and implementation of population-based cancer registries in Mexico are essential. Assessment of the future outlook of cancer in Mexico will provide awareness of future challenges and can help health systems prepare to face them.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.